Our Comprehensive Portfolio

API

Active Ingredients selected from leading pharmaceutical manufacturers under exclusivity agreements.

PROPIETARY API

APIs co-developed with European CMOs that we combine with FDF dossiers for a complete product offering to our clients.

LICENSING

FDF licenses for a wide variety of dosage form sand treatments.

We incorporate a new API every 12 months to be produced in our CMO’s factories.

We transfer this technology to our European CMOs – making them more efficient and competitive.

profit reinvestment

50% of our net profits are invested in the
co-development of molecules with our European partners.

We adquire technology to accelerate the development of Dossiers and Drug Master Files.

Select what you're interested in

Specialized Active Ingredients

Molecule

Treatment / Use

Origin

CEP

EP

USP

Potassium Clavulanate
Antibiotic
Europe
Etofenamate
Anti-Inflammatory
Europe
Gadobutrol
Contrast Media
Europe
Butylscopolamine
Gastroenterology
Europe
Nitazoxanide
Gastroenterology
Europe
Trimebutine Maleate
Gastroenterology
Europe
Brinzolamide
Ophthalmology
Europe
Latanoprost (+Bunod)
Ophthalmology
Europe
Bimatoprost
Ophthalmology
Europe
Tafluprost
Ophthalmology
Europe
Travoprost
Ophthalmology
Europe
Silodosin (Alpha)
Urology
Europe
Fulvestrant
Oncology
Europe
Nomegestrol
Gynecology
Europe
Drospirenone
Gynecology
Europe
Dienogest
Gynecology
Europe
Minocycline
Dermatology
Europe
Silver Sulfadiazine
Dermatology
Europe
Galantamine
CNS
Europe

Specialized Intermediates & Excipients

Molecule

Treatment / Use

Origin

Certificates

Metacresol (Synthetic)
Excipient
Europe
GMP
Tartaric Acid (Natural)
Excipient
Europe
FSSC
DiatrizoicAcid
Intermediate
Europe
GMP
Methyl Ester
Intermediate
Europe
GMP
Alpha Phenylglycine
Intermediate
Europe
GMP
Tertiary Butylamine
Intermediate
Europe
GMP

Licensing

Therapeutic Line

Active Substance

Dose

PH Form

Bioequivalence

MA

Dossier format

Cardiovascular
Pentoxifilin
400 mg
Tablets extended release
Yes
Yes
eCTD
Urologic
Tamsulosin
0,4 mg
Tablets extended release
Yes
Yes
eCTD
Systemic hormonal
Deflazacort
6 mg, 30 mg

Tablets

Yes
Yes
eCTD
Musculoskeletal system
Celecoxib
200 mg
Hard capsules
Yes
Yes
eCTD
Central Nervous System
Citalopram
10 mg, 20 mg
Tablets
Yes
Yes
eCTD
Central Nervous System
Duloxetin
30 mg, 60 mg
Hard capsules
Yes
Yes
eCTD
Central Nervous System
Escitalopram
10 mg, 15 mg, 20 mg
Coated tablets
Yes
Yes
eCTD
Central Nervous System
Lorazepam
1 mg
Tablets
Yes
Yes
eCTD
Central Nervous System
Venlafaxin
37 mg,5 mg, 75 mg, 150 mg
Modified realase capsules
Yes
Yes
eCTD
Central Nervous System
Clonazepam
2,5 mg/ml
Oral drops solution (bottle)
N/A
Yes

CTD

Biliary & Hepatic Therapy
Ursodeoxycholic Acid
150,250,300,450 500
Capsules
Yes
Yes

CTD

Cytotoxics
Mercaptopurine
50 mg
Tablets
Yes
Yes
eCTD
Cytotoxics
Sunitinib
12 mg,5 mg, 25 mg, 50 mg
Capsules

Yes

Yes

CTD

Central Nervous System
Methylphenidate HCl

5 mg, 10 mg, 20 mg,40 mg, 60 mg

Tablets
BE with RITALIN®
Yes

CTD

Psychiatry & Primary Care
Melatonin
2 g
Modified realase tablets
BE with CIRCADIN®
Yes

CTD

Musculoskeletal system
Paracetamol
10 mg/ml
Bottle
N/A
Yes

CTD

Gastro
Omeprazole
10, 20, 40 mg
Capsules
N/A
Yes

CTD

We also provide a wide variety of alternative substances from different origines.
For more information and to see our full product range, please get in contact with us

Contacto

logo next generation
ministerio de transformación digital
redes
plan de recuperación
kit digital
españa digital

© 2026 Capital Farma S.L